S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS

• Sarah Jungius,
• Sara Mattei,
• Simona Stivala,
• Jakub Szybinski,
• Lenka Vokalova,
• Alicia Rovó,
• Anne Angelillo-Scherrer,
• Stefan Dirnhofer,
• Sara Meyer

Affiliations

Sarah Jungius

1 University Hospital Basel and University of Basel, Department of Biomedicine, Basel, Switzerland

Sara Mattei

1 University Hospital Basel and University of Basel, Department of Biomedicine, Basel, Switzerland

Simona Stivala

1 University Hospital Basel and University of Basel, Department of Biomedicine, Basel, Switzerland

Jakub Szybinski

1 University Hospital Basel and University of Basel, Department of Biomedicine, Basel, Switzerland

Lenka Vokalova

1 University Hospital Basel and University of Basel, Department of Biomedicine, Basel, Switzerland

Alicia Rovó

3 Inselspital, Bern University Hospital and University of Bern, Department of Hematology and Central Hematology Laboratory, Switzerland

Anne Angelillo-Scherrer

2 Inselspital, Bern University Hospital and University of Bern, Department for Biomedical Research, Bern, Switzerland

Stefan Dirnhofer

4 University Hospital Basel, Department of Pathology, Switzerland

Sara Meyer

1 University Hospital Basel and University of Basel, Department of Biomedicine, Basel, Switzerland